Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

News in brief

Sun Pharma pulls chemotherapy made at Gujarat plant

By Gareth MacDonald+

03-Jul-2014
Last updated the 03-Jul-2014 at 13:26 GMT

Indian drugmaker Sun Pharmaceutical has recalled 200 vials of the cancer drug gemcitabine in the US over concerns about its sterility.

According to a report by the US Food and Drug Administration (FDA ) tests conducted on a different batch of the drug made at the same plant in Gujarat, India detected a “particle excursion” raised questions about the sterility of the recalled vials.

The withdrawal was initiated on April 9 by Sun’s unit Caraco Pharmaceutical Laboratories.

Sun Pharma declined to comment when contacted by in-Pharmatechnologist.com.

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...